IC
Invivo Capital Partners
Venture CapitalModerateInvivo is focused on investing in early-stage companies in Healthcare sector: biotech, medical devices and e-Health.
5
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Invivo Capital Partners.
Investment Thesis & Strategy
Invivo Capital Partners invests in early-stage biotech, medical device, and e-Health companies within the healthcare sector. They invest in various stages of companies.
Investment Activity
Deals per year over the last 7 years
1
20171
20182
20190
20204
20210
20223
2023Portfolio Companies
Selected investments from their portfolio of 5 companies
O
Obsidio
Healthcare · Series A, 2023
A
Apic Bio
Biotech · Series A, 2023
A
Ablaze Therapeutics
Biotech · Series A, 2023
E
EnClear Therapies
Biotech · Series A, 2021
A
Aura Biosciences
Biotech · Series B, 2021
C
Cormorant Asset Management
Healthcare · Growth, 2021
T
Tessera Therapeutics
Biotech · Series B, 2021
V
Vaxcyte
Biotech · Series B, 2019
I
Immusoft
Biotech · Series B, 2019
C
Cerevance
Biotech · Series B, 2018
K
Kiadis Pharma
Biotech · Growth, 2017
Frequently Asked Questions
Invivo Capital Partners focuses on Series A, Series B, Series C+ stage investments.